ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 200 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | – | 200 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | -99.9% | 200 | 0.0% | 0.00% | – |
Q2 2017 | $1,000,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2017 | $1,000,000 | – | 200 | 0.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 200 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 200 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 200 | 0.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
Q3 2015 | $1,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 16,013,540 | $39,233,000 | 1.19% |
ARMISTICE CAPITAL, LLC | 1,940,000 | $4,753,000 | 1.12% |
DAFNA Capital Management LLC | 234,000 | $573,000 | 0.50% |
Alpha Wave Global, LP | 1,655,162 | $4,055,000 | 0.43% |
Telemetry Investments, L.L.C. | 150,000 | $368,000 | 0.21% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,294,945 | $12,972,000 | 0.18% |
SABBY MANAGEMENT, LLC | 792,617 | $1,942,000 | 0.11% |
K2 PRINCIPAL FUND, L.P. | 443,887 | $1,088,000 | 0.10% |
Anson Funds Management LP | 105,085 | $257,000 | 0.08% |
DIALECTIC CAPITAL MANAGEMENT, LP | 25,000 | $61,000 | 0.03% |